Acquired Resistance to HER2-Targeted Therapies Creates Vulnerability to ATP Synthase Inhibition.
Gale M, Li Y, Cao J, Liu ZZ, Holmbeck MA, Zhang M, Lang SM, Wu L, Do Carmo M, Gupta S, Aoshima K, DiGiovanna MP, Stern DF, Rimm DL, Shadel GS, Chen X, Yan Q.
Gale M, et al. Among authors: yan q.
Cancer Res. 2020 Feb 1;80(3):524-535. doi: 10.1158/0008-5472.CAN-18-3985. Epub 2019 Nov 5.
Cancer Res. 2020.
PMID: 31690671
Free PMC article.